Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Grad

Showing results (171-180 of 197) with videos related to

Pageof 20
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2022
Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence in Massachusetts Estimated from Newborn Screening SpecimensKevin C Ma, Jaime E Hale, Yonatan H Grad, et al.
BMC Global and Public Health|December 16, 2024
Recommendations for the optimal introduction of novel antibiotics to treat uncomplicated gonorrhoea in the face of increasing antimicrobial resistance: a case study with zoliflodacinFernando Pascual, Carmen Au, Chido Dziva Chikwari, et al.
Mbio|January 24, 2013
Comparative genomics of recent Shiga toxin-producing Escherichia coli O104:H4: short-term evolution of an emerging pathogenYonatan H Grad, Paul Godfrey, Gustavo C Cerquiera, et al.
Nature Communications|September 17, 2020
Reductions in commuting mobility correlate with geographic differences in SARS-CoV-2 prevalence in New York CityStephen M Kissler, Nishant Kishore, Malavika Prabhu, et al.
Genome Medicine|March 31, 2021
Emergence and evolution of antimicrobial resistance genes and mutations in Neisseria gonorrhoeaeKoji Yahara, Kevin C Ma, Tatum D Mortimer, et al.
Sexually Transmitted Diseases|October 27, 2018
Antimicrobial Resistance in Neisseria gonorrhoeae: Proceedings of the STAR Sexually Transmitted Infection-Clinical Trial Group Programmatic MeetingAnthony D Cristillo, Claire C Bristow, Elizabeth Torrone, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 23, 2018
Poor Immunogenicity, Not Vaccine Strain Egg Adaptation, May Explain the Low H3N2 Influenza Vaccine Effectiveness in 2012-2013Sarah Cobey, Sigrid Gouma, Kaela Parkhouse, et al.
The Lancet. Infectious Diseases|July 19, 2016
Whole-genome sequencing to determine transmission of Neisseria gonorrhoeae: an observational studyDilrini De Silva, Joanna Peters, Kevin Cole, et al.
Plos Biology|July 12, 2021
Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategiesStephen M Kissler, Joseph R Fauver, Christina Mack, et al.
Science (New York, N.Y.)|March 25, 2020
Aggregated mobility data could help fight COVID-19Caroline O Buckee, Satchit Balsari, Jennifer Chan, et al.
Pageof 20

Showing results (171-180 of 197) with videos related to

Sort By:
Pageof 20
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2022
Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence in Massachusetts Estimated from Newborn Screening SpecimensKevin C Ma, Jaime E Hale, Yonatan H Grad, et al.
BMC Global and Public Health|December 16, 2024
Recommendations for the optimal introduction of novel antibiotics to treat uncomplicated gonorrhoea in the face of increasing antimicrobial resistance: a case study with zoliflodacinFernando Pascual, Carmen Au, Chido Dziva Chikwari, et al.
Mbio|January 24, 2013
Comparative genomics of recent Shiga toxin-producing Escherichia coli O104:H4: short-term evolution of an emerging pathogenYonatan H Grad, Paul Godfrey, Gustavo C Cerquiera, et al.
Nature Communications|September 17, 2020
Reductions in commuting mobility correlate with geographic differences in SARS-CoV-2 prevalence in New York CityStephen M Kissler, Nishant Kishore, Malavika Prabhu, et al.
Genome Medicine|March 31, 2021
Emergence and evolution of antimicrobial resistance genes and mutations in Neisseria gonorrhoeaeKoji Yahara, Kevin C Ma, Tatum D Mortimer, et al.
Sexually Transmitted Diseases|October 27, 2018
Antimicrobial Resistance in Neisseria gonorrhoeae: Proceedings of the STAR Sexually Transmitted Infection-Clinical Trial Group Programmatic MeetingAnthony D Cristillo, Claire C Bristow, Elizabeth Torrone, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 23, 2018
Poor Immunogenicity, Not Vaccine Strain Egg Adaptation, May Explain the Low H3N2 Influenza Vaccine Effectiveness in 2012-2013Sarah Cobey, Sigrid Gouma, Kaela Parkhouse, et al.
The Lancet. Infectious Diseases|July 19, 2016
Whole-genome sequencing to determine transmission of Neisseria gonorrhoeae: an observational studyDilrini De Silva, Joanna Peters, Kevin Cole, et al.
Plos Biology|July 12, 2021
Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategiesStephen M Kissler, Joseph R Fauver, Christina Mack, et al.
Science (New York, N.Y.)|March 25, 2020
Aggregated mobility data could help fight COVID-19Caroline O Buckee, Satchit Balsari, Jennifer Chan, et al.
Pageof 20